Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine Added to Bipolar Mood Disorder Treatment for Obsessive-Compulsive Symptoms
IRCT201410073930N36Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obsessive compulsive disorder (OCD) and bipolar disorder (BD) comparing Memantine add-on with Placebo add-on (2 arms). Started Sep 2014; status: completed.
02
Drugs
memantine
03
Conditions
obsessive compulsive disorder (OCD)bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT201410073930N36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201410073930N36.